• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不饱和侧链β-11-羟基六氢大麻酚类似物

Unsaturated side chain beta-11-hydroxyhexahydrocannabinol analogs.

作者信息

Busch-Petersen J, Hill W A, Fan P, Khanolkar A, Xie X Q, Tius M A, Makriyannis A

机构信息

Department of Chemistry, University of Hawaii, Honolulu 96822, USA.

出版信息

J Med Chem. 1996 Sep 13;39(19):3790-6. doi: 10.1021/jm950934b.

DOI:10.1021/jm950934b
PMID:8809166
Abstract

The cannabinoid side chain is a key pharmacophore in the interaction of cannabinoids with their receptors (CB1 and CB2). To study the stereochemical requirements of the side chain, we synthesized a series of cannabinoids in which rotation around the C1'-C2' bond is blocked. The key steps in the synthesis were the cuprate addition of a substituted resorcinol to (+)-apoverbenone, the TMSOTf-mediated formation of the dihydropyran ring, and the stereospecific introduction of the beta-11-hydroxymethyl group. All the analogs tested showed nanomolar affinity for the receptors, the cis-hept-1-ene side chain having the highest affinity for CB1 (Ki = 0.89 nM) and showing the widest separation between CB1 and CB2 affinities. The parent n-heptyl-beta-11-hydroxyhexahydrocannabinol was the least potent binding to CB1 (Ki = 8.9 nM) and had the lowest selectivity between CB1 and CB2.

摘要

大麻素侧链是大麻素与其受体(CB1和CB2)相互作用中的关键药效基团。为了研究侧链的立体化学要求,我们合成了一系列其中围绕C1'-C2'键的旋转受阻的大麻素。合成中的关键步骤包括将取代的间苯二酚的铜酸盐加成到(+)-阿朴维本酮上、TMSOTf介导的二氢吡喃环的形成以及β-11-羟甲基的立体定向引入。所有测试的类似物对受体均显示出纳摩尔亲和力,顺式庚-1-烯侧链对CB1具有最高亲和力(Ki = 0.89 nM),并且在CB1和CB2亲和力之间显示出最大差异。母体正庚基-β-11-羟基六氢大麻酚与CB1结合的效力最低(Ki = 8.9 nM),并且在CB1和CB2之间具有最低的选择性。

相似文献

1
Unsaturated side chain beta-11-hydroxyhexahydrocannabinol analogs.不饱和侧链β-11-羟基六氢大麻酚类似物
J Med Chem. 1996 Sep 13;39(19):3790-6. doi: 10.1021/jm950934b.
2
Pharmacophoric requirements for cannabinoid side chains: multiple bond and C1'-substituted delta 8-tetrahydrocannabinols.大麻素侧链的药效团要求:多键和C1'-取代的δ8-四氢大麻酚
J Med Chem. 1998 Mar 26;41(7):1195-200. doi: 10.1021/jm970277i.
3
C1'-cycloalkyl side chain pharmacophore in tetrahydrocannabinols.四氢大麻酚中的C1'-环烷基侧链药效基团。
J Med Chem. 2007 Aug 23;50(17):4048-60. doi: 10.1021/jm070121a. Epub 2007 Aug 2.
4
Pharmacophoric requirements for the cannabinoid side chain. Probing the cannabinoid receptor subsite at C1'.大麻素侧链的药效团要求。探究C1'处的大麻素受体亚位点。
J Med Chem. 2003 Jul 17;46(15):3221-9. doi: 10.1021/jm020558c.
5
Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands.在表达外周大麻素受体(CB2)的转染细胞系中评估结合情况:大麻素受体亚型选择性配体的鉴定。
J Pharmacol Exp Ther. 1996 Sep;278(3):989-99.
6
Classical/nonclassical hybrid cannabinoids: southern aliphatic chain-functionalized C-6beta methyl, ethyl, and propyl analogues.经典/非经典混合型大麻素:具有南部脂肪族链官能化的C-6β甲基、乙基和丙基类似物。
J Med Chem. 1998 Sep 10;41(19):3596-608. doi: 10.1021/jm960677q.
7
Development of a novel class of monocyclic and bicyclic alkyl amides that exhibit CB1 and CB2 cannabinoid receptor affinity and receptor activation.开发一类新型的单环和双环烷基酰胺,它们表现出对CB1和CB2大麻素受体的亲和力以及受体激活作用。
Drug Des Discov. 2000;16(4):281-94.
8
The application of 3D-QSAR studies for novel cannabinoid ligands substituted at the C1' position of the alkyl side chain on the structural requirements for binding to cannabinoid receptors CB1 and CB2.3D-QSAR研究在烷基侧链C1'位置被取代的新型大麻素配体对与大麻素受体CB1和CB2结合的结构要求方面的应用。
J Med Chem. 2007 Jun 14;50(12):2875-85. doi: 10.1021/jm0610705. Epub 2007 May 24.
9
Cannabinol derivatives: binding to cannabinoid receptors and inhibition of adenylylcyclase.大麻酚衍生物:与大麻素受体结合及对腺苷酸环化酶的抑制作用
J Med Chem. 1997 Sep 26;40(20):3228-33. doi: 10.1021/jm970126f.
10
Cannabinoid receptors CB1 and CB2: a characterization of expression and adenylate cyclase modulation within the immune system.大麻素受体CB1和CB2:免疫系统内表达及腺苷酸环化酶调节的特征
Toxicol Appl Pharmacol. 1997 Feb;142(2):278-87. doi: 10.1006/taap.1996.8034.

引用本文的文献

1
Chemistry and Pharmacology of Delta-8-Tetrahydrocannabinol.Delta-8-四氢大麻酚的化学与药理学
Molecules. 2024 Mar 11;29(6):1249. doi: 10.3390/molecules29061249.
2
Major Phytocannabinoids and Their Related Compounds: Should We Only Search for Drugs That Act on Cannabinoid Receptors?主要植物大麻素及其相关化合物:我们是否应该只寻找作用于大麻素受体的药物?
Pharmaceutics. 2021 Nov 1;13(11):1823. doi: 10.3390/pharmaceutics13111823.
3
Synthesis of Functionalized Cannabilactones.功能化 Cannabilactones 的合成。
Molecules. 2020 Feb 6;25(3):684. doi: 10.3390/molecules25030684.
4
Novel C-Ring-Hydroxy-Substituted Controlled Deactivation Cannabinergic Analogues.新型C环羟基取代的可控失活大麻素类似物
J Med Chem. 2016 Jul 28;59(14):6903-19. doi: 10.1021/acs.jmedchem.6b00717. Epub 2016 Jul 13.
5
AM841, a covalent cannabinoid ligand, powerfully slows gastrointestinal motility in normal and stressed mice in a peripherally restricted manner.AM841是一种共价大麻素配体,它能以一种外周限制的方式显著减缓正常和应激小鼠的胃肠蠕动。
Br J Pharmacol. 2015 May;172(9):2406-18. doi: 10.1111/bph.13069. Epub 2015 Feb 27.
6
Novel adamantyl cannabinoids as CB1 receptor probes.新型金刚烷类大麻素作为 CB1 受体探针。
J Med Chem. 2013 May 23;56(10):3904-21. doi: 10.1021/jm4000775. Epub 2013 May 14.
7
Identification of essential cannabinoid-binding domains: structural insights into early dynamic events in receptor activation.鉴定必需的大麻素结合域:受体激活早期动态事件的结构见解。
J Biol Chem. 2011 Sep 23;286(38):33422-35. doi: 10.1074/jbc.M111.261651. Epub 2011 Jul 27.
8
Heteroadamantyl cannabinoids.异金刚烷类大麻素。
J Med Chem. 2010 Aug 12;53(15):5656-66. doi: 10.1021/jm100390h.
9
Binding mode prediction of conformationally restricted anandamide analogs within the CB1 receptor.CB1受体中构象受限的花生四烯酸乙醇胺类似物的结合模式预测
J Mol Signal. 2008 Feb 26;3:5. doi: 10.1186/1750-2187-3-5.
10
The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin.三种植物大麻素:Δ⁹-四氢大麻酚、大麻二酚和Δ⁹-四氢大麻萜酚的不同CB1和CB2受体药理学特性
Br J Pharmacol. 2008 Jan;153(2):199-215. doi: 10.1038/sj.bjp.0707442. Epub 2007 Sep 10.